NCT05446805 · RECRUITING

Depression and Driving

This study is examining how depression, early Alzheimer's-related brain changes, and antidepressant use affect how older adults drive. Researchers will use PET brain scans and spinal fluid tests to look for amyloid and tau proteins — the biological markers tied to Alzheimer's — and then measure real-world driving behavior. The phase is unspecified, meaning this is most likely an observational study, not a treatment trial.

Inclusion criteria

  • Drive on average at least once per week
  • Has a valid driver's license
  • Willing to complete blood draw
  • Willing to complete either lumbar puncture or PET imaging
  • 65 years or older
  • Speaks English

Exclusion criteria

  • Not willing to complete blood draw and/or one other biomarker
  • Less than 65 years of age
  • Does not drive a vehicle/ is no longer actively driving

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2023-07-27

View full record on ClinicalTrials.gov

All APOE4 clinical trials